Title : Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.

Pub. Date : 2008 May 15

PMID : 18483373






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer. Tamoxifen vascular endothelial growth factor A Homo sapiens
2 RESULTS: Tamoxifen therapy resulted in an increase in platelet releasate concentrations of VEGF (P = 0.01) but no change in plasma VEGF. Tamoxifen vascular endothelial growth factor A Homo sapiens
3 In univariate analysis, aspirin use attenuated the tamoxifen-associated increase in VEGF in the platelet releasate and decreased serum levels of VEGF (P = 0.03). Tamoxifen vascular endothelial growth factor A Homo sapiens
4 CONCLUSIONS: Tamoxifen and aromatase inhibitor therapy affect VEGF and endostatin levels and likely contribute to the angiogenic balance in breast cancer patients. Tamoxifen vascular endothelial growth factor A Homo sapiens